Cargando…

PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer

BACKGROUND: Liver cancer is a prevalent and deadly form of cancer with high incidence and mortality rates. The PCMT1 protein has been linked to cell anti-apoptosis and tumor metastasis, but its significance in liver hepatocellular carcinoma (LIHC) remains largely unexplored. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiahao, Liu, Baiying, Li, Yanan, Mi, Ze, Tan, Hongpei, Rong, Pengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436427/ https://www.ncbi.nlm.nih.gov/pubmed/37596654 http://dx.doi.org/10.1186/s40001-023-01216-1

Ejemplares similares

PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer
por: Guo, Jufang, et al.
Publicado: (2022)

Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1
por: Tan, Hongpei, et al.
Publicado: (2023)

Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
por: Mi, Ze, et al.
Publicado: (2023)

Preoperative Body Composition Combined with Tumor Metabolism Analysis by PET/CT Is Associated with Disease-Free Survival in Patients with NSCLC
por: Tan, Hongpei, et al.
Publicado: (2022)

Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
por: Zhang, Yunshu, et al.
Publicado: (2023)

Wortmannin Reduces Insulin Signaling and Death in Seizure-Prone Pcmt1(−/−) Mice
por: MacKay, Kennen B., et al.
Publicado: (2012)

Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer
por: Shan, Liyun, et al.
Publicado: (2022)

Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC
por: Tan, Hongpei, et al.
Publicado: (2021)

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis
por: Zhang, Jingjing, et al.
Publicado: (2022)

PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway
por: Zhong, Jiacheng, et al.
Publicado: (2023)

PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells
por: Saiding, Aili, et al.
Publicado: (2023)

Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression
por: Tang, Feng, et al.
Publicado: (2022)

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1
por: Dong, Li-Ming, et al.
Publicado: (2021)

Tumor-Infiltrating Immune Cells: Triggers for Tumor Capsule Disruption and Tumor Progression?
por: Jiang, Bin, et al.
Publicado: (2013)

Methylation of histone H4 at aspartate 24 by Protein L-isoaspartate O-methyltransferase (PCMT1) links histone modifications with protein homeostasis
por: Biterge, Burcu, et al.
Publicado: (2014)

Neural stem cell conditioned medium alleviates Aβ25-35 damage to SH-SY5Y cells through the PCMT1/MST1 pathway
por: Jia, Guoyong, et al.
Publicado: (2020)

Retraction: Neural stem cell conditioned medium alleviates Aβ25-35 damage to SH-SY5Y cells through the PCMT1/MST1 pathway
por: Jia, Guoyong, et al.
Publicado: (2020)

Targeting YAP-dependent MDSC infiltration impairs tumor progression
por: Wang, Guocan, et al.
Publicado: (2015)

A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration
por: Mohammad Mirzaei, Navid, et al.
Publicado: (2021)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
por: Xu, Zhixing, et al.
Publicado: (2023)

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma
por: Tong, Xinya, et al.
Publicado: (2022)

DSE inhibits melanoma progression by regulating tumor immune cell infiltration and VCAN
por: Xia, Lin, et al.
Publicado: (2023)

Immune infiltration and immunophenotyping in atrial fibrillation
por: Tian, Yuqing, et al.
Publicado: (2023)

The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer
por: Xie, Wen, et al.
Publicado: (2022)

Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration
por: Fan, Yumei, et al.
Publicado: (2021)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment
por: Li, Fazhan, et al.
Publicado: (2022)

Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor
por: Osada, Takuya, et al.
Publicado: (2004)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Wang, Jingjing, et al.
Publicado: (2021)

Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia
por: Cheng, Hongyan, et al.
Publicado: (2023)

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study
por: Liu, Rong, et al.
Publicado: (2021)

Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
por: Wang, Songna, et al.
Publicado: (2022)

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
por: Xiu, Mengxi, et al.
Publicado: (2023)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
por: Huang, Yukun, et al.
Publicado: (2020)

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
por: Bi, Fangfang, et al.
Publicado: (2020)

Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer
por: Ma, Jun-Jie, et al.
Publicado: (2023)

Barriers to immune cell infiltration in tumors
por: Melssen, Marit M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r1av052brdch5kuv8nvf1ri85g